Stellantis chairman to pick Apple CFO Maestri as carmaker's new CEO

Stellantis chairman to pick Apple CFO Maestri as carmaker's new CEO - paper

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Stellantis chairman to pick Apple CFO Maestri as carmaker's new CEO - paper

Dec 3, 2024 11:37 PM

ROME, Dec 4 (Reuters) - Stellantis' ( STLA ) Chairman

John Elkann plans to name Luca Maestri, the outgoing CFO of

Apple ( AAPL ), as the new CEO of the Italian-French carmaker, newspaper

Corriere della Sera reported on Wednesday.

Reuters was not immediately able to verify the report.

(Writing by Gavin Jones, editing by Cristina Carlevaro)

Previous page： BioCardia Receives Patent for Morph DNA Transseptal Delivery Next page： Northern Trust's profit surges on fee income boost, accounting gain

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

BioCardia Receives Patent for Morph DNA Transseptal Delivery

Jul 17, 2024

08:45 AM EDT, 07/17/2024 (MT Newswires) -- BioCardia ( BCDA ) said Wednesday that it was granted a patent for its method for transseptal access to the heart using a steerable catheter based on the company's Morph DNA technology. The patent issued by the US Patent Office protects the company's products through 2035, BioCardia ( BCDA ) said. BioCardia's (...

Northern Trust's profit surges on fee income boost, accounting gain

Jul 17, 2024

(Reuters) - Asset and wealth manager Northern Trust ( NTRS ) posted a more than two-fold jump in second-quarter profit on Wednesday, thanks to higher fee income and an accounting gain of $878.4 million from a stock exchange deal with Visa. Hopes of a soft landing for the U.S. economy and investor frenzy around artificial intelligence have lifted the stock...

Immutep Receives Dutch Regulatory Approval to Begin Human Testing of Potential Autoimmune Treatment

Jul 17, 2024

08:45 AM EDT, 07/17/2024 (MT Newswires) -- Immutep ( IMMP ) said Wednesday it has received regulatory clearance from the Netherlands' ethics authority to begin human testing of its IMP761 potential autoimmune disease treatment. Immutep ( IMMP ) describes IMP761 as a LAG-3 agonist antibody to potentially treat rheumatoid arthritis, type 1 diabetes, and multiple sclerosis, among other autoimmune diseases....

Correction: Prologis Q2 Core Funds From Operations, Revenue Falls; Updates 2024 Core FFO Outlook

Jul 17, 2024

08:32 AM EDT, 07/17/2024 (MT Newswires) -- Prologis ( PLD ) reported Q2 core funds from operations Wednesday of $1.34 per diluted share, compared with $1.83 a year earlier. Analysts polled by Capital IQ expected $1.07. Total revenue for the quarter ended June 30 was $2.01 billion, down from about $2.45 billion a year earlier. Analysts surveyed by Capital IQ...